EP2270026
Compounds for proteasome enzyme inhibition
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.8.2005EP published:
18.5.2016EP application number:
10012497.3
EPO information:
European Patent Register
Max expiry date:
7.8.2025
Title:
Compounds for proteasome enzyme inhibition
Timeline
Today
8.8.2005EP application
18.5.2016EP Publication
Owner
Name:
Onyx Therapeutics, Inc.Address:
249 E. Grand Avenue, 94080, South San Francisco, CA, US
Inventor
Name:
Smyth, Mark S.Address:
San Mateso, CA, US
Name:
Laidig, Guy J.Address:
Menlo Park, CA, US
Priority
Number:
599401 PDate:
6.8.2004Country:
US
Number:
610001 PDate:
14.9.2004Country:
US
Number:
106879Date:
14.4.2005Country:
US
Classification
Categories:
C07K 5/103, C07K 5/087, C07K 5/08, A61K 38/06